{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Inadequate evaluation of drugs for COVID-19 therapy\",\"Impact\":\"Ineffective treatment for COVID-19 patients\",\"Mitigation\":\"Conducting adequate studies with realistic eligibility criteria and patient stratification\",\"Technologies\":\"Medical research and clinical trial technology\",\"People\":\"COVID-19 patients, healthcare professionals\",\"Owner\":\"Medical research institutions, regulatory authorities\"},{\"Description\":\"Spread of SARS-CoV-2 in the built environment\",\"Impact\":\"Increased risk of exposure and infection\",\"Mitigation\":\"Implementing strict prevention and protection organizational measures\",\"Technologies\":\"Access control systems, surveillance technology\",\"People\":\"Employees, visitors, travelers\",\"Owner\":\"Companies, competent health authorities\"},{\"Description\":\"Lack of compliance with quarantine and surveillance measures\",\"Impact\":\"Uncontrolled spread of COVID-19 within and across regions\",\"Mitigation\":\"Enforcing strict quarantine and surveillance measures for individuals with potential exposure\",\"Technologies\":\"Surveillance technology, travel monitoring systems\",\"People\":\"Traveling staff, individuals with potential exposure\",\"Owner\":\"Companies, competent health authorities\"}]}"}}